Atıf Formatları
Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. Nemutlu Samur Et Al. , "Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation," Neuropharmacology , vol.208, 2022

Nemutlu Samur, D. Et Al. 2022. Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation. Neuropharmacology , vol.208 .

Nemutlu Samur, D., Akçay, G., Yıldırım, S., Özkan, A., Çeker, T., Derin, N., ... Tanrıöver, G.(2022). Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation. Neuropharmacology , vol.208.

Nemutlu Samur, Dilara Et Al. "Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation," Neuropharmacology , vol.208, 2022

Nemutlu Samur, Dilara N. Et Al. "Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation." Neuropharmacology , vol.208, 2022

Nemutlu Samur, D. Et Al. (2022) . "Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation." Neuropharmacology , vol.208.

@article{article, author={Dilara Nemutlu Samur Et Al. }, title={Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation}, journal={Neuropharmacology}, year=2022}